Topics

Latest "Autonomic Regulation in Prader-Willi Syndrome" News Stories

19:49 EST 16th February 2020 | BioPortfolio

Here are the most relevant search results for "Autonomic Regulation in Prader-Willi Syndrome" found in our extensive news archives from over 250 global news sources.

More Information about Autonomic Regulation in Prader-Willi Syndrome on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Autonomic Regulation in Prader-Willi Syndrome for you to read. Along with our medical data and news we also list Autonomic Regulation in Prader-Willi Syndrome Clinical Trials, which are updated daily. BioPortfolio also has a large database of Autonomic Regulation in Prader-Willi Syndrome Companies for you to search.

Showing "Autonomic Regulation Prader Willi Syndrome" News Articles 1–25 of 3,500+

Sunday 16th February 2020

Complex Regional Pain Syndrome Pricing Market Access and Landscape 2019 [Published by First View Insight] Prices from USD $2125

Firstview Insight's Complex Regional Pain Syndrome Pricing Market Access and Landscape 2019 provides country specific insights in order to estimate market potential for Complex Regional Pain Syndrome based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeh...


SerineThreonine Protein Kinase Pim 1 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $2975

SerineThreonine Protein Kinase Pim 1 Pipeline Review, H2 2019SummaryAccording to the recently published report 'SerineThreonine Protein Kinase Pim 1 Pipeline Review, H2 2019'; Serine/Threonine Protein Kinase Pim 1 Oncogene PIM1 or PIM1 or EC 2.7.11.1 pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universi...

Wayne State researchers receive grant to develop new treatments for Barth syndrome

Barth syndrome is a rare and life-threatening, X-linked genetic disorder that primarily affects males and is passed from mother to son; women who are carriers do not show symptoms of the disorder.


Saturday 15th February 2020

Proteus Syndrome Pipeline Review2019 [Published by First View Insight] Prices from USD $1063

Firstview Insight's Proteus Syndrome Pipeline Review2019 provides an overview of the pipeline landscape of Proteus Syndrome It provides comprehensive insights of all the clinical and nonclinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the upcoming and existing...

Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic Renal Cell Carcinoma

Bristol-Myers Squibb Company (NYSE: BMY) today announced five-year follow-up results from the Phase 3 CheckMate -025 study, which continue to demonstrate that treatment with Opdivo (nivolumab) delivers superior overall survival (OS) and objective response rates (ORR) in patients with previously treated advanced or metastatic renal cell carcinoma (RCC) compared to those treated with everolimus. Th...

Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Updated results from CheckMate -214 study show that more than 50% of patients treated with Opdivo plus Yervoy were alive at 42 months compared to 39% of patients treated with sunitinib Complete response rates, per independent review, for patients treated with Opdivo plus Yervoy were maintained and ongoing in over 80% of patients Results represent the longest follow-up with any immuno-oncology...

20172025 World Neurostimulation Devices Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummaryNeurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker. Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from pro...

Wolfram syndrome 1 gene regulates pathways maintaining beta-cell health and survival

Histone Deacetylase 2 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $2975

Histone Deacetylase 2 Pipeline Review, H2 2019SummaryHistone Deacetylase 2 Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98 Histone deacetylase 2 is an enzyme encoded by the HDAC2 gene. It plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein...

Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700

Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019, provides an overview of the Middle East Respiratory Syndrome MERS Infectious Disease pipeline landscape.Middle East respiratory syndrome MERS is a viral respiratory disease caused b...

Friday 14th February 2020

Brain Abnormalities in Patients with 22q11.2 Deletion Syndrome: New Insights into Psychosis

In a study of over 500 patients, the syndrome was associated with many volume and subcortical abnormalities, more strongly so in patients with psychosis.

[Correspondence] Full spectrum of COVID-19 severity still being depicted

Chaolin Huang and colleagues1 first reported the clinical features of patients infected with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2; previously known as 2019-nCoV), which emerged in Wuhan, China. Their study will contribute to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19). Meanwhile, the conclusions have caused a certain degree of social panic.

Case Western grants Akouos rights to develop gene therapy for Usher-associated hearing loss

Case Western Reserve University granted Akouos Inc. exclusive rights to develop a gene therapy to stop the progression of hea...

Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study

Medicines and Medical Devices Bill introduced in UK

A new bill is now effective in the UK which aims to improve regulation for medical devices and ensure patient safety, as well as allow hospitals to develop personalised medicines. The post Medicines and Medical Devices B

With EU Medical Device Regulation Deadline Looming, Regulatory Pros to Gather in Brussels for ...

Rockville, MD, USA, Feb. 14, 2020 (GLOBE NEWSWIRE) Read more...

Xlife Sciences AG: Capital Increase 'Private Placement'

Xlife Sciences AG / Key word(s): Capital Increase Xlife Sciences AG: Capital Increase 'Private Placement' 14-Feb-2020 / 14:14 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Xlife Sciences AG: Capital Increase '...

Viewpoint: President Trump should end FDA-USDA turf war over animal gene-editing regulation to foster innovation

22q11.2 Deletion Syndrome (For Parents)

Source: Nemours FoundationRelated MedlinePlus Pages: Cleft Lip and Palate, Congenital Heart Defects, Immune System and Disorders

Shady Grove Fertility New York Applauds NY Governor’s Efforts to Lift Ban on Gestational Surrogacy and Showed Support of the Child-Parent Security Act during Lobby Day

New York is only one of three states in the U.S. that ban gestational surrogacy. To show active support for the millions of New York residents who need fertility assistance to build their family, SGF New York supports lobbying efforts to lift ban. NEW YORK (PRWEB) February 14, 2020 For millions of New Yorkers who face infertility, others whose cancer, previous trauma, or genetic disease has affec...

Open Call SC1-HCO-18-2020: Developing Methodological Approaches for Improved Clinical Investigation and Evaluation of High-Risk Medical Devices

In May 2017, a new Regulation on medical devices, Regulation (EU) 2017/745 entered into force that will come into effect in spring 2020. This new Regulation sets forth reinforced rules for the generation of clinical evidence: for instance, clinical investigations for high-risk devices will be compulsory and the requirements regarding the clinical evaluation throughout the product lifetime are m...

GammaAminobutyric Acid Receptor Subunit Alpha 5 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $2975

GammaAminobutyric Acid Receptor Subunit Alpha 5 Pipeline Review, H2 2019SummaryGammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 Gammaaminobutyric acid A receptor, alpha 5 or GABRA5 is a protein encoded by the GABRA5 gene. it , mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. GammaAminobut...

Thursday 13th February 2020

Wayne State University team developing new treatments for Barth syndrome

(Wayne State University - Office of the Vice President for Research) A Wayne State University research team received a $1.5 million grant from the National Institutes of Health for a grant that aims identify specific metabolites as candidates or new treatments for Barth syndrome and other cardiomyopathies.

Experimental antiviral prevents MERS-CoV in rhesus macaques

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists.

Gilead drug prevents type of coronavirus in monkeys; raises hope for China trials

An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East Respiratory Syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated i...


Quick Search

News Quicklinks